AMRX
Amneal Pharmaceuticals Inc. Earnings
$7.75
Earnings Summary
Revenue | $702.47Mn |
Net Profits | $-0.16Mn |
Net Profit Margins | -0.02% |
Amneal Pharmaceuticals Inc.’s revenue jumped 13.29% since last year same period to $702.47Mn in the Q3 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 0.1% jump in its revenue since last 3-months.
Amneal Pharmaceuticals Inc.’s net profit fell -101.61% since last year same period to $-0.16Mn in the Q3 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -102.6% fall in its net profits since last 3-months.
Amneal Pharmaceuticals Inc.’s net profit margin fell -101.42% since last year same period to -0.02% in the Q3 2024. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated -102.6% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Amneal Pharmaceuticals Inc. post its latest quarter earningsEPS Estimate Current Quarter | 0.13 |
EPS Estimate Current Year | 0.13 |
Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -7.14% fall from last quarter’s estimates.
Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.13.
Key Ratios
Key ratios of the Amneal Pharmaceuticals Inc. post its Q3 2024 earningsEarning Per Share (EPS) | 0.16 |
Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -15.79% since last year same period to 0.16 in the Q3 2024. This indicates that the Amneal Pharmaceuticals Inc. has generated -15.79% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-12 | 0.13 | 0.16 | 23.08% |
2024-05-08 | 0.09 | 0.14 | 55.56% |
2024-08-09 | 0.14 | 0.16 | 14.29% |
₹0 US Stocks a/c Opening Fee